Nab‐paclitaxel‐based compared to docetaxel‐based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neckAmy E. Schell, Douglas R. Adkins, Jessica Ley et al.|Cancer Medicine|2015Cited by 30
648 A pilot study to evaluate the combination of zimberelimab, domvanalimab and etrumadenant in patients with previously treated non-small cell lung cancer (NSCLC)Anjali Rohatgi, Daniel Morgensztern, Maria Q. Baggstrom et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0